These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38577760)

  • 1. A nationwide phase II study of delayed local treatment for children with high-risk neuroblastoma: The Japan Children's Cancer Group Neuroblastoma Committee Trial JN-H-11.
    Yoneda A; Shichino H; Hishiki T; Matsumoto K; Ohira M; Kamijo T; Kuroda T; Soejima T; Nakazawa A; Takimoto T; Yokota I; Teramukai S; Takahashi H; Fukushima T; Hara J; Kaneko M; Ikeda H; Tajiri T; Mugishima H; Nakagawara A
    Pediatr Blood Cancer; 2024 Jun; 71(6):e30976. PubMed ID: 38577760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial.
    Ladenstein R; Pötschger U; Pearson ADJ; Brock P; Luksch R; Castel V; Yaniv I; Papadakis V; Laureys G; Malis J; Balwierz W; Ruud E; Kogner P; Schroeder H; de Lacerda AF; Beck-Popovic M; Bician P; Garami M; Trahair T; Canete A; Ambros PF; Holmes K; Gaze M; Schreier G; Garaventa A; Vassal G; Michon J; Valteau-Couanet D;
    Lancet Oncol; 2017 Apr; 18(4):500-514. PubMed ID: 28259608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).
    Hishiki T; Matsumoto K; Ohira M; Kamijo T; Shichino H; Kuroda T; Yoneda A; Soejima T; Nakazawa A; Takimoto T; Yokota I; Teramukai S; Takahashi H; Fukushima T; Kaneko T; Hara J; Kaneko M; Ikeda H; Tajiri T; Nakagawara A;
    Int J Clin Oncol; 2018 Oct; 23(5):965-973. PubMed ID: 29700636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: a prospective multicenter study.
    Rujkijyanont P; Photia A; Traivaree C; Monsereenusorn C; Anurathapan U; Seksarn P; Sosothikul D; Techavichit P; Sanpakit K; Phuakpet K; Wiangnon S; Chotsampancharoen T; Chainansamit SO; Kanjanapongkul S; Meekaewkunchorn A; Hongeng S
    BMC Cancer; 2019 Oct; 19(1):961. PubMed ID: 31619207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
    Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ
    Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a prospective clinical trial JN-L-10 using image-defined risk factors to inform surgical decisions for children with low-risk neuroblastoma disease: A report from the Japan Children's Cancer Group Neuroblastoma Committee.
    Iehara T; Yoneda A; Yokota I; Takahashi H; Teramukai S; Kamijyo T; Nakazawa A; Takimoto T; Kikuta A; Yagyu S; Ikeda H; Nakagawara A; Tajiri T;
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27914. PubMed ID: 31342649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification.
    Kaneko M; Tsuchida Y; Mugishima H; Ohnuma N; Yamamoto K; Kawa K; Iwafuchi M; Sawada T; Suita S
    J Pediatr Hematol Oncol; 2002 Nov; 24(8):613-21. PubMed ID: 12439032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid COJEC versus standard induction therapies for high-risk neuroblastoma.
    Peinemann F; Tushabe DA; van Dalen EC; Berthold F
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD010774. PubMed ID: 25989478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of induction chemotherapy in children older than 18 months with stage-4 neuroblastoma treated with an adaptive-to-response modified N7 protocol (mN7).
    Mora J; Cruz O; Lavarino C; Rios J; Vancells M; Parareda A; Salvador H; Suñol M; Carrasco R; Guillen A; Mañé S; de Torres C
    Clin Transl Oncol; 2015 Jul; 17(7):521-9. PubMed ID: 25596034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroblastoma.
    Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
    Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial.
    Pearson AD; Pinkerton CR; Lewis IJ; Imeson J; Ellershaw C; Machin D; ;
    Lancet Oncol; 2008 Mar; 9(3):247-56. PubMed ID: 18308250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: a report from the Children's Oncology Group.
    Zage PE; Kletzel M; Murray K; Marcus R; Castleberry R; Zhang Y; London WB; Kretschmar C;
    Pediatr Blood Cancer; 2008 Dec; 51(6):747-53. PubMed ID: 18704922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment combined with bone marrow transplantation for advanced neuroblastoma: an analysis of patients who were pretreated intensively with the protocol of the Study Group of Japan.
    Ohnuma N; Takahashi H; Kaneko M; Uchino J; Takeda T; Iwafuchi M; Ohhira M; Nishihira H; Mugishima H; Yokoyama J
    Med Pediatr Oncol; 1995 Mar; 24(3):181-7. PubMed ID: 7838040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival of children with advanced neuroblastoma treated by intensified therapy including myeloablative chemotherapy with stem cell transplantation: a retrospective analysis from the Tohoku Neuroblastoma Study Group.
    Imaizumi M; Watanabe A; Kikuta A; Takano T; Ito E; Shimizu T; Tsuchiya S; Iinuma K; Konno T; Ohi R; Hayashi Y;
    Tohoku J Exp Med; 2001 Oct; 195(2):73-83. PubMed ID: 11846211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survivors of advanced neuroblastoma with MYCN amplification: A report of 19 patients surviving disease-free for more than 66 months.
    Kawa K; Ohnuma N; Kaneko M; Yamamoto K; Etoh T; Mugishima H; Ohhira M; Yokoyama J; Bessho F; Honna T; Yoshizawa J; Nakada K; Iwafuchi M; Nozaki T; Mimaya J; Sawada T; Nakamura T; Miyata H; Yamato K; Tsuchida Y
    J Clin Oncol; 1999 Oct; 17(10):3216-20. PubMed ID: 10506621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
    Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
    J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.
    Cheung NK; Kushner BH; LaQuaglia M; Kramer K; Gollamudi S; Heller G; Gerald W; Yeh S; Finn R; Larson SM; Wuest D; Byrnes M; Dantis E; Mora J; Cheung IY; Rosenfield N; Abramson S; O'Reilly RJ
    Med Pediatr Oncol; 2001 Jan; 36(1):227-30. PubMed ID: 11464891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Neuroblastoma with a Novel Delayed Intensification Chemotherapy.
    Zhang YT; Chang J; Xu HM; Li YN; Zhong XD; Liu ZL
    Indian J Pediatr; 2019 Feb; 86(2):126-131. PubMed ID: 30076520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology.
    Coze C; Hartmann O; Michon J; Frappaz D; Dusol F; Rubie H; Plouvier E; Leverger G; Bordigoni P; Béhar C; Beck D; Mechinaud F; Bergeron C; Plantaz D; Otten J; Zucker JM; Philip T; Bernard JL
    J Clin Oncol; 1997 Dec; 15(12):3433-40. PubMed ID: 9396394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloablative combination chemotherapy without total body irradiation for neuroblastoma.
    Kushner BH; O'Reilly RJ; Mandell LR; Gulati SC; LaQuaglia M; Cheung NK
    J Clin Oncol; 1991 Feb; 9(2):274-9. PubMed ID: 1899111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.